Burnett A F, Coe F L, Klement V, O'Meara A T, Muderspach L I, Roman L D, Morrow C P
Division of Gynecologic Oncology, University of Southern California, Los Angeles, California 90033, USA.
Gynecol Oncol. 2000 Dec;79(3):438-43. doi: 10.1006/gyno.2000.5965.
The goal of this study was to develop a device which will elevate the small intestine out of the pelvic cavity during radiation after radical surgery.
A prosthetic device of silicone plastic was designed which conforms to the pelvis. This device is filled with saline and renograffin for X-ray visualization. The capacity of the device is between 750 and 1500 cc. A small bowel contrast radiograph is performed prior to radiation to document exclusion from the radiation field. The device remains in place throughout radiation therapy and is then removed through a small incision after draining the contents of the prosthesis.
Seven devices have been placed to date. The patients' age ranged from 35 to 65 years. All women had stage Ib1 carcinoma of the cervix and all underwent a type III radical hysterectomy with bilateral pelvic and common iliac lymphadenectomy. The indication for placement of the device was deep invasion of tumor in five patients, close margin in one patient, and positive pelvic lymph nodes in one patient. The amount of fluid instilled in the device ranged from 960 to 1200 cc. All patients had a return to normal bowel function within 3 days of surgery. All had radiologically documented exclusion of the small intestine from the radiation field prior to beginning radiation. In the postoperative period there was one major complication: a pulmonary embolism documented by pulmonary angiogram on postoperative day 2. All seven patients completed planned radiotherapy. The devices have been removed, with no adhesions to the prosthesis.
The results of this study determine that the feasibility, safety, and efficacy of a prosthetic device in displacing the small bowel from the radiation field following radical surgery are sufficient to warrant a large-scale study. The device should be applicable to any and all tumors that require high dose pelvic radiation. It is expected that displacement of the small intestine from the radiation field will diminish overall complications and may allow delivery of radiation doses that approach colon and bladder tolerance.
本研究的目的是开发一种装置,在根治性手术后放疗期间将小肠提升出盆腔。
设计了一种符合骨盆形状的硅塑料假体装置。该装置填充有生理盐水和泛影葡胺用于X线显影。该装置的容量在750至1500立方厘米之间。在放疗前进行小肠造影以记录小肠被排除在放疗野之外。该装置在整个放疗过程中都留在原位,然后在排出假体内容物后通过一个小切口取出。
迄今为止已放置了7个装置。患者年龄在35至65岁之间。所有女性均为Ib1期宫颈癌,均接受了III型根治性子宫切除术及双侧盆腔和髂总淋巴结清扫术。放置该装置的指征为5例患者肿瘤侵犯较深,1例患者切缘接近,1例患者盆腔淋巴结阳性。注入装置的液体量在960至1200立方厘米之间。所有患者在术后3天内肠道功能恢复正常。所有患者在开始放疗前经放射学证实小肠被排除在放疗野之外。术后有1例主要并发症:术后第2天经肺血管造影证实为肺栓塞。所有7例患者均完成了计划的放疗。装置已被取出,与假体无粘连。
本研究结果表明,一种假体装置在根治性手术后将小肠移出放疗野的可行性、安全性和有效性足以保证进行大规模研究。该装置应适用于任何需要高剂量盆腔放疗的肿瘤。预计将小肠移出放疗野可减少总体并发症,并可能允许给予接近结肠和膀胱耐受剂量的放疗。